Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.56 |
| ▸ | TUBB | P07437 | 1/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.56 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.56 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.56 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.56 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.56 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.56 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.56 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.56 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29771971 | 1.00 | STS (0.70) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL3484026 | 0.87 | RAB9A (0.66) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL6616664 | 0.87 | MAPT (0.69) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL29573531 | 0.87 | MAPT (0.64) | STSNPC1MAPTNPSR1HTT | |
| SCHEMBL50229 | 0.87 | MAPT (0.64) | STSNPC1MAPTNPSR1HTT | |
| SCHEMBL31286496 | 0.86 | RAB9A (0.67) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL1584218 | 0.86 | RAB9A (0.67) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL8439039 | 0.86 | ALDH1A1 (0.64) | STSNPC1MAPTNPSR1HTT | |
| SCHEMBL11576796 | 0.85 | MAPT (0.66) | STSNPC1KMT2AMAPTNPSR1 | |
| SCHEMBL6905154 | 0.85 | KMT2A (0.59) | STSNPC1KMT2AMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926265-B | Low-carbon environment-friendly high-performance rubber composition, preparation method thereof and tire | 山东华勤橡胶科技有限公司 | 2023-08-22 | — | — | CN | claimed |
| CN-115926265-A | Low-carbon environment-friendly high-performance rubber composition, preparation method thereof and tire | 山东华勤橡胶科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-12148883-B2 | Lithium secondary battery | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-11-19 | — | — | US | disclosed |
| CN-111727525-B | Lithium secondary battery | 松下知识产权经营株式会社 | 2024-07-02 | — | — | CN | disclosed |
| CN-111684645-B | Lithium secondary battery | 松下知识产权经营株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-114855295-B | Spinning solution, heat-resistant creep-resistant fiber and preparation method thereof | 东华大学 | 2024-04-05 | — | — | CN | disclosed |
| US-20240102204-A1 | SPINNING SOLUTION, HEAT-RESISTANT CREEP-RESISTANT FIBER AND PREPARATION METHOD THEREFOR | DONGHUA UNIVERSITY (CN) | 2024-03-28 | — | — | US | disclosed |
| EP-4283026-A1 | SPINNING STOCK SOLUTION, AND HEAT-RESISTANT CREEP-RESISTANT FIBER AND PREPARATION METHOD THEREFOR | Donghua University (CN) | 2023-11-29 | — | — | EP | disclosed |
| CN-115926265-B | Low-carbon environment-friendly high-performance rubber composition, preparation method thereof and tire | 山东华勤橡胶科技有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-115926265-A | Low-carbon environment-friendly high-performance rubber composition, preparation method thereof and tire | 山东华勤橡胶科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-114855295-A | Spinning solution, heat-resistant creep-resistant fiber and preparation method thereof | 东华大学 | 2022-08-05 | — | — | CN | disclosed |
| EP-1572707-A1 | NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, PHARMACEUTICAL PRODUCTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | Aventis Pharma Deutschland GmbH (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-20050014704-A1 | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2005-01-20 | — | — | US | disclosed |
| WO-2004052902-A1 | NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, PHARMACEUTICAL PRODUCTS CONTAINING SAID COMPOUNDS AND THE USE THEREOF | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-06-24 | — | — | WO | disclosed |
| EP-0299379-B1 | PENTADIENAMIDE PAF-ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-21 | — | — | EP | disclosed |
| US-4975438-A | ANTICOAGULANT | HOFFMANN-LA ROCHE INC. (US) | 1990-12-04 | — | — | US | disclosed |
| US-4788206-A | CARDIOVASCULAR DISORDERS, PLATELETS | HOFFMANN-LA ROCHE INC. (US) | 1988-11-29 | — | — | US | disclosed |
| US-4175945-A | PLANT GROWTH REGULATORS FOR TABACCO | ROHM AND HAAS COMPANY (US) | 1979-11-27 | — | — | US | disclosed |
| US-4120687-A | CONTROLLING GROWTH OF TOBACCO SUCKERS | MEISINGER ROBERT H | 1978-10-17 | — | — | US | disclosed |
| US-4115413-A | ACID FREE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014704-A1 | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | SLC5A2, SLC5A1, UGGT1 | STS 1111/4885NPC1 517/4885KMT2A 4498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.